OINNet — Online International News Network

Judge approves $7.25 billion Roundup cancer settlement

Bayer's deal covers current and future non-Hodgkin lymphoma claims from users of the weedkiller.

Authenticity Score: 83/100 across 1 source(s). First reported: 2026-11-21T14:02:03Z. Updated: 2026-11-21T20:21:01Z.

A federal judge has approved Bayer's $7.25 billion settlement resolving cancer claims linked to Roundup weedkiller. The agreement covers both existing non-Hodgkin lymphoma cases and future claims from users who develop the illness.

Verified Key Facts

A federal judge has approved a $7.25 billion settlement from Bayer to resolve lawsuits alleging its Roundup weedkiller causes cancer, according to court records.

The settlement covers two groups: users who already have non-Hodgkin lymphoma and those who may develop the illness in the future. The deal resolves one of the largest mass tort cases in U.S. history.

Bayer inherited the Roundup litigation when it acquired Monsanto, the product's original manufacturer, in 2018. The company has faced thousands of lawsuits over glyphosate, the active ingredient in Roundup.

Corroborating Sources